Company intelligence / Profile preview

Nucletron

Veenendaal, Utrecht, Netherlands

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Nucletron is the historical global leader in brachytherapy equipment and software for cancer treatment, offering precise radiotherapy solutions now integrated into Elekta's portfolio; commercial products are used in clinical practice globally, with strong clinical evidence supporting brachytherapy for multiple cancer indications

Therapeutic areas: Oncology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Academic research partners, universities, hospitals (via Brachy Academy)Isodose Control BVElekta

Beyond the preview

Go deeper on Nucletron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucletron.

Explore the full profile